Equities analysts expect Castlight Health Inc (NYSE:CSLT) to announce earnings of ($0.05) per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Castlight Health’s earnings. The highest EPS estimate is ($0.03) and the lowest is ($0.06). Castlight Health reported earnings of ($0.01) per share in the same quarter last year, which suggests a negative year over year growth rate of 400%. The company is expected to issue its next earnings report on Wednesday, February 21st.

On average, analysts expect that Castlight Health will report full year earnings of ($0.23) per share for the current fiscal year, with EPS estimates ranging from ($0.24) to ($0.21). For the next fiscal year, analysts anticipate that the company will report earnings of ($0.08) per share, with EPS estimates ranging from ($0.12) to ($0.04). Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover Castlight Health.

Castlight Health (NYSE:CSLT) last announced its quarterly earnings results on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. Castlight Health had a negative net margin of 45.14% and a negative return on equity of 32.57%. The firm had revenue of $34.60 million for the quarter, compared to analyst estimates of $34.61 million. During the same period last year, the business earned ($0.05) EPS. Castlight Health’s revenue for the quarter was up 35.7% compared to the same quarter last year.

CSLT has been the topic of a number of recent research reports. BidaskClub lowered shares of Castlight Health from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 24th. Canaccord Genuity upgraded shares of Castlight Health from a “hold” rating to a “buy” rating in a research note on Tuesday, October 10th. Cantor Fitzgerald restated a “hold” rating and issued a $5.00 price objective on shares of Castlight Health in a research note on Wednesday, October 25th. Chardan Capital dropped their price objective on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating on the stock in a research note on Thursday, October 26th. Finally, Zacks Investment Research upgraded shares of Castlight Health from a “hold” rating to a “buy” rating and set a $4.50 price objective on the stock in a research note on Monday, October 30th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $5.22.

Castlight Health (NYSE CSLT) traded up $0.15 during midday trading on Thursday, reaching $3.90. 608,779 shares of the company’s stock were exchanged, compared to its average volume of 295,917. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03. Castlight Health has a one year low of $3.05 and a one year high of $5.50.

In other news, President Robert Derek Newell bought 30,000 shares of the stock in a transaction dated Friday, October 27th. The shares were acquired at an average price of $3.95 per share, with a total value of $118,500.00. Following the completion of the acquisition, the president now directly owns 128,671 shares in the company, valued at $508,250.45. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO John C. Doyle sold 13,686 shares of Castlight Health stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the sale, the chief executive officer now directly owns 123,705 shares in the company, valued at approximately $458,945.55. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,778 shares of company stock worth $84,411. 37.43% of the stock is currently owned by company insiders.

Several large investors have recently modified their holdings of CSLT. TIAA CREF Investment Management LLC boosted its holdings in shares of Castlight Health by 2.1% in the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock valued at $394,000 after acquiring an additional 2,210 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Castlight Health by 7.6% in the first quarter. Vanguard Group Inc. now owns 2,673,760 shares of the software maker’s stock valued at $9,760,000 after acquiring an additional 189,359 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Castlight Health by 2.7% in the first quarter. Geode Capital Management LLC now owns 306,367 shares of the software maker’s stock valued at $1,118,000 after acquiring an additional 8,057 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of Castlight Health by 6.7% in the first quarter. Schwab Charles Investment Management Inc. now owns 198,594 shares of the software maker’s stock valued at $725,000 after acquiring an additional 12,483 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in shares of Castlight Health by 54.2% in the second quarter. Rhumbline Advisers now owns 65,904 shares of the software maker’s stock valued at $274,000 after acquiring an additional 23,170 shares in the last quarter. 42.55% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/12/17/0-05-eps-expected-for-castlight-health-inc-cslt-this-quarter.html.

About Castlight Health

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Get a free copy of the Zacks research report on Castlight Health (CSLT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.